Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
This grant funds the validation of high-quality markers for clinical studies in cancer.
About this program
The Assay Validation of High Quality Markers for Clinical Studies in Cancer grant aims to support research that focuses on the development and validation of biomarkers that can be used in clinical studies related to cancer. This grant is intended for researchers and institutions engaged in cancer research, particularly those looking to enhance the accuracy and reliability of clinical assays. By providing funding for this purpose, the grant seeks to improve the overall quality of cancer studies and ultimately contribute to better patient outcomes. Eligible applicants include academic institutions, nonprofit organizations, and other entities involved in cancer research. The grant encourages innovative approaches to assay validation, with a focus on high-quality markers that can be reliably used in clinical settings. The funding will support various aspects of the validation process, including experimental design, data analysis, and the dissemination of findings to the broader scientific community.
Eligibility
Academic institutions, nonprofit organizations, and other entities involved in cancer research.